What is the phosphate concentration of 2.67 mmol/L expressed in mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Phosphate Conversion: 2.67 mmol/L = 8.26 mg/dL

A phosphate concentration of 2.67 mmol/L equals 8.26 mg/dL.

Conversion Calculation

The conversion between mmol/L and mg/dL for phosphate uses the following formula:

  • mg/dL = mmol/L × 3.1 (using the molecular weight of phosphorus: 31 g/mol)

Therefore: 2.67 mmol/L × 3.1 = 8.26 mg/dL

Clinical Context

This phosphate level of 8.26 mg/dL represents severe hyperphosphatemia in any clinical context 1:

  • Normal range: 2.5-4.5 mg/dL (0.81-1.45 mmol/L) in general population
  • CKD Stage 5/Dialysis target: 3.5-5.5 mg/dL (1.13-1.78 mmol/L) 1
  • Your value of 8.26 mg/dL is approximately 1.8-3.3 times the upper limit of normal

Standard Conversion Factors for Phosphate

Multiple guidelines confirm the conversion relationship 1:

  • 1 mmol/L = 3.1 mg/dL
  • 1 mg/dL = 0.32 mmol/L

For reference, the evidence shows consistent use of these conversions across clinical contexts:

  • 2.5 mg/dL = 0.81 mmol/L 1
  • 4.5 mg/dL = 1.45 mmol/L 1
  • 5.5 mg/dL = 1.78 mmol/L 1

Clinical Significance: A phosphate level this elevated (8.26 mg/dL) would require immediate intervention in any patient population, particularly those with chronic kidney disease where it significantly increases mortality risk 2, 3.

References

Research

Mild hyperphosphatemia and mortality in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005

Research

The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.